Original paper
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments.To determine whether convalescent plasma transfusion may be beneficial in the treatment of critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Case series of 5 critically ill patients with laboratory-confirmed COVID-19 and acute respiratory distress...
Figures & Tables
Figure 1. Temporal Changes of Cycle Threshold Value, PAO2/FIO2, SOFA Score, and ...
Figure 2. Changes of Receptor Binding Domain–Specific IgG and IgM ELISA and Neut...
Table 2. Comparison of Viral Load, Clinical Indexes, and Laboratory Results Befo...
Table 3. Characteristics and Antibody Titer of Convalescent Plasma Donors
Paper Details
Title
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Published Date
Mar 27, 2020
Journal
Volume
323
Issue
16
Pages
1582 - 1582
TrendsPro
You’ll need to upgrade your plan to Pro
Looking to understand a paper’s academic impact over time?
- Scinapse’s Citation Trends graph enables the impact assessment of papers in adjacent fields.
- Assess paper quality within the same journal or volume, irrespective of the year or field, and track the changes in the attention a paper received over time.
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.